Alkermes
ALKS
#2133
Rank
A$13.30 B
Marketcap
A$79.81
Share price
4.26%
Change (1 day)
80.97%
Change (1 year)

Alkermes (ALKS) - Total assets

Total assets on the balance sheet as of March 2026 : A$6.16 Billion

According to Alkermes's latest financial reports the company's total assets are A$6.16 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Alkermes - Total assets on balance sheet (from 2001 to 2026)

Total assets by year

Year Total assets Change
2025-12-31A$3.71 B12.35%
2024-12-31A$3.30 B5.4%
2023-12-31A$3.13 B8.64%
2022-12-31A$2.88 B3.35%
2021-12-31A$2.79 B10.13%
2020-12-31A$2.53 B-1.67%
2019-12-31A$2.57 B-0.46%
2018-12-31A$2.59 B12.53%
2017-12-31A$2.30 B-3.88%
2016-12-31A$2.39 B-5.98%
2015-12-31A$2.54 B8.64%
2014-12-31A$2.34 B
2013-03-31A$1.41 B2.13%
2012-03-31A$1.38 B215.79%
2011-03-31A$0.43 B-21.82%
2010-03-31A$0.56 B-30.89%
2009-03-31A$0.81 B13.73%
2008-03-31A$0.71 B1.25%
2007-03-31A$0.70 B4.1%
2006-03-31A$0.67 B54.16%
2005-03-31A$0.43 B22.36%
2004-03-31A$0.35 B-15.45%
2003-03-31A$0.42 B-35.45%
2002-03-31A$0.65 B-18.9%
2001-03-31A$0.80 B

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Johnson & Johnson
JNJ
A$291.09 B 4,617.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
A$171.75 B 2,683.70%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
A$300.83 B 4,775.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
A$214.70 B 3,379.93%๐Ÿ‡ซ๐Ÿ‡ท France
Bristol-Myers Squibb
BMY
A$125.30 B 1,930.87%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
A$165.20 B 2,577.62%๐Ÿ‡ฌ๐Ÿ‡ง UK
Zogenix
ZGNX
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Acorda Therapeutics
ACOR
A$0.11 B-98.08%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
A$58.01 B 840.33%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel